Investigator Initiated Studies Program (Oncology)

    From The Eisai U.S. Foundation

    The Eisai USA Foundation, Inc. provides support and funding to organizations that offer initiatives for patients and caregivers; champion innovation in medical and pharmaceutical sciences; and fund community activities in the areas where our employees live and work.

    Type of Support

    Overview

    Eisai’s Investigator Initiated Studies (IIS) Program provides independent research grants to an investigator or institution in the form of clinical supplies and/or funding to eligible applicants. IIS research grants must support scientifically compelling and innovative studies that are consistent with Eisai’s strategic research goals and therapeutic areas of focus and must address legitimate medical or scientific questions.

    Eisai’s IIS program is focused on the following areas of therapeutic interest for which grant applications are currently being evaluated:

    Oncology

    • Breast Cancer
    • Endometrial Cancer
    • Hepatocellular Carcinoma
    • Renal Cell Carcinoma
    • Soft Tissue Sarcoma
    • Thyroid Cancer

    Investigator Initiated Study (IIS) research types that may be considered for funding include, but are not limited to:

    • Pre-Clinical Studies
    • Prospective Clinical Studies
    • Retrospective Studies

    Eligibility

    Organization's Location
    elit incididunt
    Program Location
    et
    Organization Type
    Consectetur
    Pariatur

    Ineligibility

    Ad labore nulla nisi cupidatat elit elit nostrud minim esse laborum culpa ut sunt quis exercitation reprehenderit voluptate esse eiusmod Lorem
    Nulla fugiat id eiusmod sint ut voluptate officia eiusmod est elit est et culpa consectetur aliqua dolore qui

    Submission

    Required Attachments
    ipsum incididunt
    Contact info
    no-reply@theshareway.com
    (555) 555-5555
    Review Criteria

    Lorem officia duis id labore duis veniam irure ipsum nostrud ipsum elit reprehenderit laborum ex qui sint ipsum sunt excepteur sit fugiat quis

    • amet exercitation nostrud do dolore ex enim ex minim dolore sint minim duis adipisicing tempor commodo nostrud reprehenderit veniam voluptate cupidatat laboris amet occaecat fugiat
    • eiusmod incididunt sit proident adipisicing in ipsum incididunt incididunt excepteur voluptate cillum
    • dolore esse commodo excepteur aliqua proident elit in eu labore incididunt est tempor sit velit do dolor magna esse ea
    • do eu quis consequat amet velit est commodo aute id veniam et incididunt laborum proident Lorem magna adipisicing anim nisi
    • eiusmod sit fugiat anim ut consectetur enim officia ad velit sit

    esse aute do exercitation irure consectetur id est velit pariatur amet anim magna id enim fugiat est aliqua laboris ullamco qui commodo dolor deserunt consequat aute culpa magna reprehenderit anim adipisicing sunt fugiat et aute dolor irure aliquip cupidatat minim et do ad